News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,058 Results
Type
Article (13611)
Company Profile (109)
Press Release (248338)
Section
Business (87956)
Career Advice (464)
Deals (15328)
Drug Delivery (64)
Drug Development (36541)
Employer Resources (49)
FDA (6262)
Job Trends (6187)
News (150053)
Policy (14012)
Tag
Academia (435)
Alliances (23136)
Alzheimer's disease (361)
Approvals (6268)
Artificial intelligence (66)
Bankruptcy (143)
Best Places to Work (4348)
Biotechnology (44)
Breast cancer (60)
Cancer (399)
Career advice (406)
Cell therapy (56)
Clinical research (30551)
Collaboration (194)
Compensation (79)
COVID-19 (748)
C-suite (58)
Data (425)
Diabetes (59)
Diagnostics (1241)
Drug pricing (59)
Earnings (31581)
Employer resources (43)
Events (36892)
Executive appointments (217)
FDA (6486)
Funding (128)
Gene therapy (62)
GLP-1 (301)
Government (1270)
Healthcare (3530)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5832)
Job creations (2050)
Job search strategy (372)
Layoffs (168)
Legal (3413)
Lung cancer (55)
Manufacturing (110)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9564)
Metabolic disorders (185)
Neuroscience (471)
NextGen Class of 2024 (1580)
Non-profit (591)
Northern California (490)
Obesity (109)
Opinion (111)
Patents (63)
People (28547)
Pharmaceutical (67)
Phase I (7948)
Phase II (12923)
Phase III (11606)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3178)
Radiopharmaceuticals (116)
Rare diseases (105)
Real estate (2629)
Regulatory (9878)
Research institute (563)
Resumes & cover letters (55)
Southern California (488)
Startups (1625)
United States (4824)
Vaccines (114)
Weight loss (81)
Date
Today (17)
Last 7 days (222)
Last 30 days (832)
Last 365 days (12481)
2024 (12416)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (43)
Asia (19867)
Australia (2565)
California (1152)
Canada (670)
China (137)
Colorado (46)
Connecticut (47)
Europe (38903)
Florida (180)
Illinois (133)
Indiana (95)
Japan (51)
Kansas (51)
Maryland (171)
Massachusetts (986)
Minnesota (64)
New Jersey (494)
New York (321)
North Carolina (292)
Northern California (490)
Pennsylvania (312)
South America (498)
Southern California (488)
Texas (158)
Virginia (45)
Washington State (78)
262,058 Results for "curtana pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Curtana Pharmaceuticals Signs Development and Manufacturing Agreement with Catalent for Brain Cancer Drug CT-179
Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical company, today announced that it has signed an agreement with Catalent to support tablet formulation and manufacturing of Curtana’s CT-179, a drug therapy for the treatment of glioblastoma (GBM), medulloblastoma (MB), and other brain cancers.
July 16, 2021
·
3 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
FDA
Curtana Pharmaceuticals’ CT-179 Receives Rare Pediatric Disease Designation from the U.S. FDA for the Treatment of Medulloblastoma
Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical company, today announced that the Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to CT-179, the company’s lead Olig2 inhibitor, for the treatment of medulloblastoma (MB).
October 7, 2020
·
3 min read
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Press Releases
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
November 27, 2024
·
1 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Press Releases
Zentalis Pharmaceuticals Announces Key Management Appointments
December 13, 2024
·
6 min read
Press Releases
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
December 20, 2024
·
8 min read
1 of 26,206
Next
